Final Reminder: Eagle Pharmaceuticals to Host 2016 Investor Day in New York City
--RSVP Requested If Not Already Registered--
Public Company Information:
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (NASDAQ:EGRX) today issued a final reminder regarding its previously announced 2016 Investor Day. The event will be held on Friday, November 11, 2016 at the Pierre Hotel located at 2 East 61st Street, New York City. The meeting, which also will be webcast live, will begin promptly at 8:00 a.m. Eastern Standard Time (EST) and end at approximately 11:30 a.m. EST. Breakfast and registration will begin at 7:00 a.m.
Institutional investors and analysts who have not already registered and are interested in attending the event can RSVP to Lisa Wilson, Investor Relations for Eagle Pharmaceuticals, either via telephone at 1-212-452-2793 or e-mail at email@example.com.
Institutional investors and analysts unable to attend in person are invited to listen to the investor meeting via a live audio webcast which can be viewed on the Investor Relations section of the Company's website at www.eagleus.com.
A webcast replay will be available for on-demand listening shortly after the completion of the event for 90 days, at the aforementioned section, also at www.eagleus.com .
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.